GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma have?
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma has 56 citations in the OpenAlex counts ScholarIQ stores.
When was GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma published?
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma has 2022 year in the ScholarIQ index.
What is the open-access status of GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma?
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma has gold oa status in the ScholarIQ index.
What is the DOI of GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma?
The DOI for GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma is on the source record.
What is the PMID of GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma?
The PMID for GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma is on the source record.
What is the OpenAlex record for GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma?
The OpenAlex for GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma is on the source record.